Will Commission heed COCIR’s Comprehensive And Sometimes Radical Solutions To MDR Delays?
Executive Summary
Industry’s timely compliance with the EU’s new medtech regulations is under threat. Will the European Commission consider potential solutions from COCIR as a persuasive factor for change?
You may also be interested in...
Commission Offers Glimpse Of Actions To Speed Up MDR Compliance
With a sense of desperation building among stakeholders over the challenges in ensuring all products are compliant with the Medical Device Regulation in time, high-level solutions are being considered. But a further MDR delay is not an option.
EU Reference Laboratory Candidates Invited To Apply In Context of IVDR Regulation
The highest risk IVDs are due to receive an extra layer of regulatory scrutiny in the EU. But it is taking a long time to set up the structures needed.
Latest Italian Designation Means Germany And Italy Are Home To Half EU’s MDR Notified Bodies
While each new designation of a notified bodies in the medtech space is good news, many more organizations are needed rapidly to help manage growing demand. Capacity warnings continue.